Novartis has confirmed that the ashes of CEO Daniel Vasella's mother have been stolen and his holiday home set fire to.
Novartis has confirmed that the ashes of CEO Daniel Vasella’s mother have been stolen and his holiday home set fire to. The company believe animal rights militants to be behind the attack.
The fire, at Vasella’s lodge in Bach, Austria, was started last Monday and has been confirmed as arson. It came a week after his mother’s ashes were stolen and “Drop HLS Now” was spray painted on the grave.
Theses incidents follow a long list of recent attacks against the company. A few weeks ago threatened messages aimed at Vasella and Novartis were written on the church in Vasella’s village of Risch in central Switzerland. According to a report by CNBC, one of the messages read: “Vasella is a killer. We are watching you. Death to Vasella. We’ll be back.”
The Stop Huntington Animal Cruelty group which campaigns against animal testing at the British laboratory, Huntingdon Life Sciences, has denied any involvement in the attacks.
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.